Sabinsa Corporation manufactures and markets phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals for nutritional, pharmaceutical and food industries. Sabinsa has carved a niche for itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff. Founded in 1988 by Muhammed Majeed, Ph.D., Sabinsa is a company dedicated to the principles of tradition, innovation and research. Sabinsa's efforts have begun to earn the company vast recognition, in addition to growing sales.
East Windsor, N.J. (April 4, 2017) – Sabinsa Corporation, the world leader in Curcumin for the dietary supplements industry, has prevailed on all counts in its long-running patent-infringement lawsuit against Olive Lifesciences Pvt. Ltd., which was filed in the United States District Court for the District of New Jersey on July 30, 2014.
The lawsuit alleged that Olive was selling and distributing products that infringed Sabinsa’s Curcumin C3 Complex® Patent, U.S. Patent No. 5,861,415, which protects compositions, methods of use, and methods of extraction of Sabinsa’s curcumin ingredient in the U.S. The Court determined that Olive “acted willfully in infringing Plaintiff’s protected product.” Accordingly, the Court ruled against Olive and in favor of Sabinsa in the amount of $2,233,258.90.
“This case, in addition to the numerous others in which Sabinsa has prevailed, shows that other companies cannot simply violate Sabinsa’s intellectual property without facing consequences,” said Sabinsa Founder Dr. Muhammed Majeed. In just the past three years, Sabinsa has resolved several U.S. intellectual property lawsuits in its favor, including patent-infringement lawsuits against Prakruti Products Private Limited, HerbaKraft Inc., NutriBioLink LLC, Chemill Inc., Nachurel Ingredients LLC., and now Olive Lifesciences Pvt. Ltd. “I hope those considering violating Sabinsa’s intellectual property will take heed, and develop their own intellectual property instead of attempting to misappropriate Sabinsa’s,” Dr. Majeed said.
“For years Sabinsa has invested substantially in developing its intellectual property portfolio and conducting science-based research. The result has been superior products that some unscrupulous suppliers have unlawfully imitated,” said James H. Hulme, a Partner at Arent Fox LLP, who represents Sabinsa in IP infringement matters. “The multi-million dollar judgment against Olive should send a loud and clear message that Sabinsa will aggressively protect its investment to the fullest extent of the law, and that infringers will be called to account for their infringement of Sabinsa’s intellectual property,” Mr. Hulme further noted.
Curcumin C3 Complex® is a Registered Trademark and Patented product of Sabinsa Corp., and is protected under U.S. Patent No. 5,861,415, and International Patents and Patents Pending. The name C3 Complex was chosen to represent the ingredient’s three main chemical compounds: Curcumin, Demethoxycurcumin & Bisdemethoxycurcumin, collectively known as Curcuminoids. Curcumin C3 Complex® is a specific mixture of Curcuminoids, making it a unique form of Curcumin quite different from generic Curcumin extracts. It has been used in more clinical studies than any other Curcumin ingredient in the world.
For more information, visit www.sabinsa.com and www.curcuminoids.com.
About Sabinsa Corporation
Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 29 years, Sabinsa has brought to market more than 100 standardized botanical extracts, and privately funded clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full-time scientists conducting ongoing research in India and the United States, Sabinsa and parent company Sami Labs Ltd. continue to develop, patent and manufacture phytonutrients for the world market, with ingredients that are both Halal and Kosher.
For more information, visit www.sabinsa.com.